Exercise safety protocols for multiple myeloma bone disease patients remain inconsistent across clinical trials, according to a scoping review examining literature from 1946 to October 2025. While physical activity is widely considered safe for individuals with myeloma, researchers found that published evidence specifically addressing bone disease lacks standardized reporting on adverse events and screening procedures.
Scoping Review Findings and Methodology
Following the Joanna Briggs Institute framework, researchers searched PubMed, OVID-MEDLINE, and CINAHL to evaluate exercise interventions that included patients with multiple myeloma bone disease, also known as MMBD. Out of 12 studies meeting inclusion criteria, none focused exclusively on participants with the bone condition. Across a combined total of 346 participants in these trials, the reported prevalence of MMBD ranged from 69% to 86%. According to the review data, trials documented seven exercise-related adverse events, but researchers failed to specify whether those incidents occurred in patients presenting with bone disease.
Assessment and Screening Gaps
Most analyzed studies utilized medical clearance, imaging, or standardized tools to evaluate participant suitability before beginning an exercise regimen. However, screening procedures varied widely between trials. Haematological considerations were generally absent from the evaluation process. Common exclusion criteria barred patients with spinal instability, spinal cord compression, or high fracture risks from participating in the physical interventions. Interventions spanned all disease stages and typically involved tailored aerobic and resistance exercise delivered by physiotherapists in supervised or unsupervised settings. Despite this professional oversight, practitioner experience, specific exercise modifications for bone disease, and bone-related outcome measures were infrequently documented.
Clinical Implications and Future Directions
The review concludes that while physical activity appears safe for patients presenting with bone disease under strict exclusion criteria, the lack of standardized reporting hampers clinical translation. Inconsistent documentation of adverse events, baseline bone characteristics, and tailored adaptations points to an urgent need for targeted clinical trials. Future research must focus exclusively on patients with bone involvement and utilize standardized, bone-specific outcome measures to guide clinical practice effectively.
Did You Know?
Frequently Asked Questions
Is exercise safe for multiple myeloma patients?
Yes, exercise is generally considered safe for patients with myeloma, provided they undergo proper medical screening and adhere to specific exclusion criteria regarding bone health, according to recent scoping review data.
What are the main risks of exercise for multiple myeloma bone disease patients?
Patients with bone involvement face risks related to spinal instability, spinal cord compression, and potential fractures, which require careful clinical screening before starting an exercise program.
Why is standardized reporting important for exercise trials in myeloma?
Inconsistent documentation of adverse events, bone disease characteristics, and exercise modifications limits the ability of clinicians to safely translate trial findings into everyday practice.
Want to stay informed on the latest clinical research and oncology updates? Subscribe to our newsletter or explore more articles on our website for evidence-based healthcare reporting.